Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive DeclineReview Published on 2022-10-092023-07-11 Journal: Frontiers in bioscience (Elite edition) [Category] COVID19(2023년), [키워드] Alzheimer's disease Anti-inflammatory Anti-oxidant anti-viral phytochemicals ARDS chalcones cognition and memory flavones long COVID disease Neuroinflammation neuroprotection. Nrf2 Parkinson's Disease SARS-CoV-2 [DOI] 10.31083/j.fbe1404027 PMC 바로가기 [Article Type] Review
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones상업적으로 이용 가능한 플라보놀은 이소플라본 및 플라본보다 더 나은 SARS-CoV-2 억제제입니다Article Published on 2022-06-302022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, [키워드] 50% effective concentration acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Anti-inflammatory anti-SARS-CoV-2 apigenin Atazanavir Better Calu Calu-3 calu-3 cells circulating class comparable Compound coronavirus COVID-19 COVID-19 treatment different disease different diseases drugs evaluate ExoN exonuclease Fisetin flavone flavones flavonoids flavonol flavonols fruits Genistein humoral immune response hydroxyl hydroxyl group hydroxyl groups IMPROVE in silico inhibit SARS-CoV-2 inhibiting inhibitor isoflavone kaempferol Luteolin M pro Modification molecular molecular docking myricetin natural product Orientation potency protease Protease. quercetin SARS-CoV-2 Seven severe acute respiratory syndrome Coronavirus target TNF-α Treatment Vaccines variants variants of concern [DOI] 10.3390/v14071458 PMC 바로가기 [Article Type] Article